Successful treatment of refractory Guillain-Barré syndrome with alemtuzumab in a patient with chronic lymphocytic leukemia.
Acta Haematol
; 132(2): 240-3, 2014.
Article
en En
| MEDLINE
| ID: mdl-24853856
ABSTRACT
This is the case of a 79-year-old man with chronic lymphocytic leukemia who presented with Guillain-Barré syndrome with features overlapping with the Miller Fisher syndrome and Bickerstaff brainstem encephalitis and positive antiganglioside GQ1b antibody about 6 months after treatment with bendamustine and rituximab. His clinical and neurologic condition continued to deteriorate despite sequential treatment with corticosteroids, intravenous immunoglobulin and plasmapheresis, but in the end, he had a complete and durable response to treatment with alemtuzumab.
Buscar en Google
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Leucemia Linfocítica Crónica de Células B
/
Síndrome de Guillain-Barré
/
Anticuerpos Monoclonales Humanizados
Tipo de estudio:
Etiology_studies
Idioma:
En
Revista:
Acta Haematol
Año:
2014
Tipo del documento:
Article